AMGN vs NMRK · P/E 24, rev $10.05B vs P/E 33, rev $1.73B
Amgen Inc (AMGN) versus Newmark Group Inc (NMRK) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Newmark Group Inc (NMRK) is a real estate services company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported NMRK revenue for 2026-06-30 was $1.73B. Net income was $34.1M. NMRK currently screens at market cap $3.08B and trailing P/E 33.1.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. NMRK currently screens at market cap $3.08B and trailing P/E 33.1.
Not investment advice. Open the AMGN and NMRK stock pages for the full models.
Not investment advice.